Universe Pharmaceuticals UPC
NASDAQ UPC
$4.30 -0.48 (-9.80%)
As of: Sep 30, 2026 · 11:57 AM EDT

Universe Pharmaceuticals (UPC) Short term Debt (2025)

Updated

Universe Pharmaceuticals (UPC) recorded Short term Debt of $2.11 trillion in the quarter ended Sep 30, 2025.

Analysis

Universe Pharmaceuticals (UPC) Short term Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Universe Pharmaceuticals 2.19 Mn -1,525.28 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2,107.04 Bn
API Access

Universe Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=UPC&period=max&api_key=YOUR_API_KEY